Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Eur J Immunol. 2019 Jul;49(7):1092-1106. doi: 10.1002/eji.201848037. Epub 2019 May 8.
Diabetes mellitus (DM) is a serious global health problem currently affecting over 450 million people worldwide. Defining its interaction with major global infections is an international public health priority. Melioidosis is caused by Burkholderia pseudomallei, an exemplar pathogen for studying intracellular bacterial infection in the context of DM due to the 12-fold increased risk in this group. We characterized immune correlates of survival in peripheral blood of acute melioidosis patients with and without DM and highlight different immune response patterns. We demonstrate the importance of circulating NK cells and show that CX3CR1 expression on lymphocytes is a novel correlate of survival from acute melioidosis. Furthermore, excessive serum levels of IL-15 and IL-18BP contribute to poor outcome independent of DM comorbidity. CD8 T cells and granzyme B expression in NK cells are important for survival of non-DM patients, whereas high antibody titers against B. pseudomallei and double-negative T cells are linked to survival of DM patients. Recall responses support a role of γδ T-cell-derived IFN-γ in the establishment of protective immunity in the DM group. Defining the hallmarks of protection in people with DM is crucial for the design of new therapies and vaccines targeting this rapidly expanding risk group.
糖尿病(DM)是一个严重的全球健康问题,目前全球有超过 4.5 亿人受到影响。定义其与主要全球感染的相互作用是国际公共卫生的优先事项。类鼻疽是由伯克霍尔德菌引起的,由于该人群的风险增加了 12 倍,因此它是研究糖尿病背景下细胞内细菌感染的典范病原体。我们描述了伴有和不伴有糖尿病的急性类鼻疽患者外周血中与生存相关的免疫相关性,并强调了不同的免疫反应模式。我们证明了循环 NK 细胞的重要性,并表明淋巴细胞上的 CX3CR1 表达是急性类鼻疽生存的一个新的相关因素。此外,IL-15 和 IL-18BP 的血清水平过高会导致不良预后,而与糖尿病合并症无关。CD8 T 细胞和 NK 细胞中的 granzyme B 表达对非糖尿病患者的生存很重要,而针对 B. pseudomallei 的高抗体滴度和双阴性 T 细胞与糖尿病患者的生存有关。回忆反应支持 γδ T 细胞衍生的 IFN-γ 在 DM 组中建立保护性免疫的作用。确定糖尿病患者的保护特征对于针对这一快速扩张的高危人群的新疗法和疫苗的设计至关重要。